The unique value proposition of the Pathfinder medical laser solution is that it represents the most effective and least invasive alternative for the treatment of benign prostatic hyperplasia currently available on the market. This is the ONLY minimally invasive BPH treatment alternative that accomplishes the objective of the current gold standard of care: trans-urethral resection of the prostate (TURP), which is to remove redundant prostatic tissue, delivering clinically proven short-term and long-term results, hence the results of laser treatment mirror those considered to be the most effective.
Given the procedures can be performed in an office-based environment, under local anesthetic, in a virtually bloodless field, with patients returning home the next day, our surgical lasers represent the least invasive way to accomplish this treatment objective. Furthermore, there is no risk associated with delayed tissue degeneration or implantable devices which may require removal at a future date. Consider the long-term effect and alternatives of the ‘minimally invasive’ decision you make today. Ask yourself, “Will a future treatment be required and what does that imply relative to the decision you are making today?”